Discussions

The vaccine is a biological agent that enhances immunity to a particular disease. Over time, it has evolved from traditional prophylactic uses to more complicated therapeutic products. Cancer vaccine development is a pathway from discovery research to clinical evaluation of putative protective antigens. The process is unique, capital-intensive, and risky. Given the significance of safety with biologics, the vaccine industry is highly valued.

There are a lot of challenges in the field of cancer vaccine development. it is essential to be in balance with cost, risks, and benefits, in addition to finding safe and effective antigens, adjuvants, and delivery systems. Today, Creative Biolabs makes efforts to meet the steadily growing demands for novel cancer vaccines and accelerate vaccine design, development, and manufacturing through international collaboration and continuous innovation of technologies.